Patents by Inventor Christopher Grupen

Christopher Grupen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080047027
    Abstract: Methods for the activation of nuclear transferred embryos using elevated calcium levels introduced into cells, and a maturation promoting factor (MPF) inhibitor are described. Elevated calcium levels introduced into the embryo cells from a culture medium containing elevated calcium levels, in the range 2 mM to about 12 mM, followed directly and immediately by incubation with DMAP are described. Also described are animals produced from embryos so treated.
    Type: Application
    Filed: December 14, 2006
    Publication date: February 21, 2008
    Applicants: Relag Pty Ltd., Garelag Pty Ltd.
    Inventors: Christopher Grupen, Mark Nottle
  • Publication number: 20070033667
    Abstract: Methods for the production of nuclear transfer embryos, nuclear transfer embryos and animals derived therefrom are described. The method generally comprises at least the steps of: providing at least one enucleated recipient cell; providing at least one donor cell or nucleus; providing a fusion media which is substantially free of calcium; placing said at least one enculeated recipient cell and at least one donor cell or nucleus in contact with one another to form couplets; and, fusing via electrofusion in said fusion media said at least one recipient cell with at least one donor cell or nucleus to form a nuclear transfer embryo.
    Type: Application
    Filed: September 14, 2006
    Publication date: February 8, 2007
    Applicants: Garelag Pty Ltd., Relag Pty Ltd.
    Inventors: Andrew Boquest, Christopher Grupen, Mark Nottle